Vanda Pharma (VNDA) Buy Rating and $15 PT Reiterated - Jefferies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Vanda Pharma (VNDA) Buy Rating and $15 PT Reiterated - Jefferies

Vanda Pharmaceuticals (VNDA) Tops Q1 EPS by 7c

May 4, 2016 5:31 PM EDT

Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q1 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $33.3 million versus the consensus estimate of $32.57 million.

2016 Financial Guidance

Vanda reiterates its prior 2016 financial guidance and expects to achieve the following... More